drugset / Trial / NCT06776679
A Study of How [14C]-BGB-16673 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Participants
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the absorption, metabolism, and excretion of \[14C\]-BGB-16673 and to characterize and determine, where possible, the metabolites present in plasma, urine, and feces in healthy male participants following a single oral administration.
Timeline
- Start
- 2025-01-24
- Primary completion
- 2025-03-27
- Completion
- 2025-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGB-16673 | Other / unclassified | — | Oral |
Indications
No indication recorded.